2021
GRANTED US PATENTS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (US9637739B2; US10844378B2)
- Systems and methods for barcoding nucleic acids (US10596541B2; US11052368B2)*
- System and method for a biomimetic fluid processing (US10343163B2; US10710073B2; US9795965B1)*
- Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus Thermophilus (US10385336B2)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (US8822146B2)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (US8889352B2; US9505797B2)
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (US9725467B2)
- Nucleic acid production and sequence analysis (US9347093B2; US9988673B2)
- New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases (US8008007B2)*
- Process for the production of monoclonal antibodies using chimeric VLPS (US7919314B2)
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (US8314132B2)
- Analysis of single-stranded RNA (US11008605B2).
GRANTED EU PATENTS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (EP2828386B1)
- Systems and methods for barcoding nucleic acids (EP3134536B1; EP3299469B1)*
- System and method for a biomimetic fluid processing (EP2941642B1)*
- Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus Thermophilus (EP3189140B1)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (EP2414527B1)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (EP2414528B1)
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (EP2914583B1)
- Nucleic acid production and sequence analysis (EP2776575B1)
- Production of selenoproteins (selprot) (EP3019194B1)
- Analysis of single-stranded RNA (EP3271478B1)
- System and method for synthesis of DNA particles and use thereof (EP3402594B1)*
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (EP2268626B1)
- New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases (EP1874790B1)*
- Benzimidazo [1,2-C][1,2,3] thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof (EP2054420B1)
GRANTED JP PATENTS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (JP6423338B2)
- System and method for a biomimetic fluid processing (JP6429794B2)*
- New s-adenosyl-L methionine analogues with extended activated groups for transfer by methyltransferases (JP08008007B2)*
- Systems and methods for barcoding nucleic acids (JP6853667B2)*
PATENT APPLICATIONS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (US20150291961A1; US20180187195A1; JP2019030321A; JP2021019617A)
- Systems and methods for barcoding nucleic acids (US20150298091A1; EP3456846A1; US20210379555A1)*
- System and method for a biomimetic fluid processing (US20200316597A1)*
- System and method for producing target biological substances (EP3712612A1)*
- Selective inhibitors of carbonic anhydrase (US20180222856A1; EP3328833A1)
- System and method for synthesis of DNA particles and use thereof (US20190002943A1)*
- Production of cyclic adenylates and their use as allosteric regulators (EP3630966A1); US20210130799A1
- Methods for the identification and characterization of double-strand break sites and compositions and uses thereof (US20210147909A1; EP3790993A1)*
- Characterization of prostate cancer using DNA methylation assay (PCT/IB2019/056204)
- N 4-modified cytidine nucleotides and their use (EP3681897A1; US20200270295A1)
- Systems and methods for encapsulation and multi-step processing of biological samples (WO2020255108A1; US20200400538A1)*
- Method for generating functional protein sequences with generative adversarial networks (WO2021059066A1)*
- Methods and compositions for noninvasive prenatal diagnosis through targeted covalent labeling of unmodified genomic sites (WO2021198726A1)
- Clear cell renal cell carcinoma biomarkers and uses thereof (US63128874)*
- Carbonic anhydrase inhibitors synthesized on interconnecting linker chains (PCT/IB2021/061310)
- Antibodies For Photoactive Protein Manipulation (EP21187460.7)
- Catalytic biomolecule activity recording into DNA sequence (EP3864168A1*; US20210355486A1*)
2020
GRANTED US PATENTS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (US9637739B2; US10844378B2)
- Systems and methods for barcoding nucleic acids (US10596541B2)*
- System and method for a biomimetic fluid processing (US10343163B2; US10710073B2; US9795965B1)*
- Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus Thermophilus (US10385336B2)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (US8822146B2)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (US8889352B2; US9505797B2)
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (US9725467B2)
- Nucleic acid production and sequence analysis (US9347093B2; US9988673B2)
- New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases (US8008007B2)*
- Process for the production of monoclonal antibodies using chimeric VLPS (US7919314B2)
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (US8314132B2)
GRANTED EU PATENTS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (EP2828386B1)
- Systems and methods for barcoding nucleic acids (EP3134536B1; EP3299469B1)*
- System and method for a biomimetic fluid processing (EP2941642B1)*
- Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus Thermophilus (EP3189140B1)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (EP2414527B1)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (EP2414528B1)
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (EP2914583B1)
- Nucleic acid production and sequence analysis (EP2776575B1)
- Production of selenoproteins (selprot) (EP3019194B1)
- Analysis of single-stranded RNA (EP3271478B1)
- System and method for synthesis of DNA particles and use thereof (EP3402594B1)*
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (EP2268626B1)
- New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases (EP1874790B1)*
- Benzimidazo [1,2-C][1,2,3] thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof (EP2054420B1)
GRANTED JP PATENTS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (JP6423338B2)
- System and method for a biomimetic fluid processing (JP6429794B2)*
- New s-adenosyl-L methionine analogues with extended activated groups for transfer by methyltransferases (JP08008007B2)⃰
PATENT APPLICATIONS
- RNA-directed DNA cleavage by the Cas9-crRNA complex (US20150291961A1; US20180187195A1; JP2019030321A)
- Systems and methods for barcoding nucleic acids (US20150298091A1; US20180304222A1; JP2017515469A)*
- System and method for a biomimetic fluid processing (US20200316597A1; US16646593A1; CN105308452A1)*
- System and method for producing target biological substances (EP3712612A1)⃰
- Selective inhibitors of carbonic anhydrase (US20180222856A1; EP3328833A1)
- Analysis of single-stranded RNA (US20180251814A1)
- System and method for synthesis of DNA particles and use thereof (US20190002943A1)*
- Production of cyclic adenylates and their use as allosteric regulators (EP3630966A1)
- Methods for the identification and characterization of double-strand break sites and compositions and uses thereof (WO2019217816A1)*
- Characterization of prostate cancer using DNA methylation assay (PCT/IB2019/056204)
- N 4-modified cytidine nucleotides and their use (EP3681897A1; US20200270295A1)
- Systems and methods for encapsulation and multi-step processing of biological samples (PCT/IB2020/057266)⃰;
- Method for generating functional protein sequences with generative adversarial networks (PCT/IB2020/058401)⃰
- Methods and compositions for noninvasive prenatal diagnosis through targeted covalent labeling of unmodified genomic sites (PCT/IB2020/053011)
- Clear cell renal cell carcinoma biomarkers and uses thereof (US63128874)⃰
2019
GRANTED US PATENTS
- New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases (US 8822146 B2)
- Process for the production of monoclonal antibodies using chimeric VLPS (US7919314 B2)
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3- thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (US8314132 B2)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (US8889352 B2)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (US 8822146 B2)
- Nucleic acid production and sequence analysis (US9347093 B2)
- Analysis of methylation sites (US9347093 B2)*
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (US9725467 B2)
- RNA-directed DNA cleavage by the CAS9-CRRNA complex (US 9637739 B2)
- Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus (US10385336 B2).
- System and method for a biomimetic fluid processing US10343163B2)
GRANTED EU PATENTS
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3- thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (EP2268626B1)
- New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases (EP1874790B1)
- Benzimidazo [1,2-C][1,2,3] thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof (EP2054420B1)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (EP2414528B1)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (EP2414527B1)
- Nucleic acid production and sequence analysis (M-tagPrimer) (EP2776575B1)
- Production of selenoproteins EP3019194 (B1)
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (EP2914583B1)
- RNA-directed DNA cleavage by the Cas9-crRNA complex. (EP2828386B1)
- Programmable RNA Shredding by the Type III-A CRISPR-Cas System of Streptococcus thermophilus (EP3189140 B1)
PATENT APPLICATIONS
- System and method for a biomimetic fluid processing (US20150336095A1; EP2941642A1; CA2896997A1; Nr. CN105308452A1)*
- System and method for synthesis of DNA particles and use thereof (US20190002943A1)
- Systems and methods for barcoding nucleic acids* US2018304222 (A1) US2015298091 (A1) US2018071705 (A1)
- Analysis of methylation sites (EP2594651A1)*
- RNA-directed DNA cleavage by the Cas9-crRNA complex (US2018187195 (A1) CA2867849 (A1) EA201491728 (A1) HK1206392 (A1) US2015045546 (A1) US2015050699 (A1) US2015240261 (A1) US2015291961 (A1) WO2013142578 (A1)
- Analysis of single-stranded RNA US2018251814 (A1) EP3271478 (A1) WO2016148556 (A1)
- Selective inhibitors of carbonic anhydrase US2018222856 (A1) EP3328833 (A1) WO2017017505 (A1)
- Targeted RNA knockdown and knockout by Type III-A Csm complexes US20180105835 (A1)
- Systems and methods for encapsulation and multi-step processing of biological samples US62863881;
- N 4-modified cytidine nucleotides and their use WO/2019/053609
2018
GRANTED US PATENTS
- New s-adenosyl-L methionine analogues with extended activated groups for transfer by methyltransferases (US 8822146 B2)
- Process for the production of monoclonal antibodies using chimeric VLPS (US7919314 B2)
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (US8314132 B2)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (US8889352 B2)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (US 8822146 B2)
- Nucleic acid production and sequence analysis (US9347093 B2)
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (US9725467 B2)
- RNA-directed DNA cleavage by the CAS9-CRRNA complex (US 9637739 B2)
GRANTED EU PATENTS
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (EP2268626B1)
- New s-adenosyl-L methionine analogues with extended activated groups for transfer by methyltransferases (EP1874790B1)
- Benzimidazo [1,2-C][1,2,3] thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof (EP2054420B1)
- Derivatization of biomolecules by covalent coupling of noncofactor compounds using methyltransferases (EP2414528B1)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (EP2414527B1)
- Nucleic acid production and sequence analysis (EP2776575B1)
- Production of selenoproteins EP3019194 (B1)
PATENT APPLICATIONS
- System and method for a biomimetic fluid processing (US20150336095A1; EP2941642A1; CA2896997A1; Nr. CN105308452A1)*
- System and method for synthesis of DNA particles and use thereof (US20190002943A1) 3. Systems and methods for barcoding nucleic acids* US2018304222 (A1) US2015298091 (A1) US2018071705 (A1)
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (EP2914583A1)
- Analysis of methylation sites (EP2594651A1)*
- RNA-directed DNA cleavage by the Cas9-crRNA complex (US2018187195 (A1) CA2867849 (A1) EA201491728 (A1) EP2828386 (A1) HK1206392 (A1) US2015045546 (A1) US2015050699 (A1) US2015240261 (A1) US2015291961 (A1) WO2013142578 (A1)
- Analysis of single-stranded RNA US2018251814 (A1) EP3271478 (A1) WO2016148556 (A1)
- Selective inhibitors of carbonic anhydrase US2018222856 (A1) EP3328833 (A1) WO2017017505 (A1)
2017
GRANTED US PATENTS
- New s-adenosyl-L methionine analogues with extended activated groups for transfer by methyltransferases (US 8822146 B2)
- Process for the production of monoclonal antibodies using chimeric VLPS (US7919314 B2)
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (US8314132 B2)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (US8889352 B2)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (US 8822146 B2)
- Nucleic acid production and sequence analysis (US9347093 B2)
- Analysis of methylation sites (US9347093 B2)*
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (US9725467 B2)
- RNA-directed DNA cleavage by the CAS9-CRRNA complex (US 9637739 B2)
GRANTED EU PATENTS
- 5-Aryl-4(5-substituted 2,4-dihydraxyphenyl)-1,2,3-thiadiazoles as inhibitors of HSP90 chaperone and the intermediates for production thereof (EP2268626B1)
- New s-adenosyl-L methionine analogues with extended activated groups for transfer by methyltransferases (EP1874790B1)
- Benzimidazo [1,2-C][1,2,3] thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof (EP2054420B1)
- Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases (EP2414528B1)
- Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases (EP2414527B1)
- Nucleic acid production and sequence analysis (M-tag-Primer) (EP2776575B1)
PATENT APPLICATIONS
- System and method for a biomimetic fluid processing (US20150336095A1; EP2941642A1; CA2896997A1; Nr. CN105308452A1)*
- Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase (EP2914583A1)
- Analysis of methylation sites (EP2594651A1)*
- Production of selenoproteins (EP3019194A1)
* Jointly owned patent with a foreign research organization and/or company
